Valeant Needs To Be Open And Transparent

Screen Shot 2015-10-26 at 2.26.09 PM

Steve Odland appeared on CNBC October 26,2015 to discuss the Valeant Pharmaceutical situation.  The independent committee of the board will need quickly to investigate the issue with Philidor and communicate openly and transparently to their customers and the investment community.

This entry was posted in Board of Directors and tagged , , . Bookmark the permalink.